Jeffrey Flier
Director/Board Member bei SCHOLAR ROCK HOLDING CORPORATION
Vermögen: 395 551 $ am 31.03.2024
Profil
Jeffrey S.
Flier is currently the Director at Scholar Rock, Inc., the Independent Director at Scholar Rock Holding Corp., a Director at the Institute For Protein Innovation, Inc., and a Member of the National Academy of Medicine (United States).
He is also a Professor at Harvard Medical School.
Previously, he served as the Director of the Harvard NeuroDiscovery Center, Inc. and Sigilon Therapeutics, Inc. He was a Professor at Harvard University from 2007 to 2016 and the Chief Academic Officer at Beth Israel Deaconess Medical Center, Inc. from 2002 to 2007.
Additionally, he was a Trustee at Partners In Health.
Dr. Flier obtained his doctorate degree from the Icahn School of Medicine at Mount Sinai in 1972 and also holds an undergraduate degree from The City College of New York.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.06.2023 | 22 272 ( 0,03% ) | 395 551 $ | 31.03.2024 |
Aktive Positionen von Jeffrey Flier
| Unternehmen | Position | Beginn |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 01.10.2016 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Director/Board Member | 22.11.2016 |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | 01.09.2007 |
Institute For Protein Innovation, Inc.
 Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jeffrey Flier
| Unternehmen | Position | Ende |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Director/Board Member | 10.06.2020 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.08.2016 |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2007 |
Harvard NeuroDiscovery Center, Inc.
 Harvard NeuroDiscovery Center, Inc. BiotechnologyHealth Technology Harvard NeuroDiscovery Center, Inc. operates as a pioneering biomedical research group focused on ending suffering from neurodegenerative and psychiatric diseases. The company was founded in 2001 and is headquartered in Boston, MA. | Director/Board Member | - |
| ░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ausbildung von Jeffrey Flier
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
| The City College of New York | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Commercial Services |
Partners In Health
 Partners In Health Miscellaneous Commercial ServicesCommercial Services Partners In Health provides healthcare facilities for the poor. It has operations in Haiti, Rwanda, Peru, Russia, the USA, Malawi, and Lesotho. The company was founded by Ophelia Dahl, Paul Farmer, Jim Yong Kim, Todd McCormack and Tom White in 1987 and is headquartered in Boston, MA. | Commercial Services |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
Harvard NeuroDiscovery Center, Inc.
Harvard NeuroDiscovery Center, Inc. BiotechnologyHealth Technology Harvard NeuroDiscovery Center, Inc. operates as a pioneering biomedical research group focused on ending suffering from neurodegenerative and psychiatric diseases. The company was founded in 2001 and is headquartered in Boston, MA. | Health Technology |
Institute For Protein Innovation, Inc.
Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Commercial Services |
